NCT01116232 2019-03-26Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell TransplantationBarbara Ann Karmanos Cancer InstitutePhase 2 Terminated4 enrolled 4 charts
NCT00621036 2018-11-26Vaccine Therapy and GM-CSF in Treating Patients With CNS LymphomaUniversity of Texas Southwestern Medical CenterPhase 2 Withdrawn
NCT00416624 2017-02-10Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by ChemotherapyMayo ClinicPhase 2 Completed239 enrolled 23 charts